Expression of cell adhesion molecule CD44 in gastric adenocarcinoma and its prognostic importance

World Journal of Gastroenterology

Volumn 14, Issue 41, 2008, Pages 6376-6381

  Ghaffarzadehgan, Kamran ^a   Jafarzadeh, Mostafa ^b   Raziee, Hamid Reza ^a   Sima, Hamid Reza ^c,d   Esmaili Shandiz, Ehsan ^b   Hosseinnezhad, Hanieh ^b,e   Taghizadeh Kermani, Ali ^a   Moaven, Omeed ^b   Bahrani, Maryam ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Cell adhesion molecules; Cluster of differentiation 44; Gastric cancer; Immunohistochemistry; Survival rate

Indexed keywords

HERMES ANTIGEN; CD44 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PARTIAL GASTRECTOMY; PROGNOSIS; STOMACH ADENOCARCINOMA; TOTAL STOMACH RESECTION; ADENOCARCINOMA; CANCER STAGING; CELL DIFFERENTIATION; GASTRECTOMY; IMMUNOLOGY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; STOMACH MUCOSA; STOMACH TUMOR; TIME; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; CELL DIFFERENTIATION; FEMALE; GASTRECTOMY; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; STOMACH NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 63449136494     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.6376     Document Type: Article

References (31)

1. Henson DE, Dittus C, Younes M, Nguyen H, Albores-Saavedra J. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type. Arch Pathol Lab Med 2004; 128: 765-770
2. Abbaszadegan MR, Moaven O, Sima HR, Ghafarzadegan K, A'rabi A, Forghani MN, Raziee HR, Mashhadinejad A, Jafarzadeh M, Esmaili-Shandiz E, Dadkhah E. p16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer. World J Gastroenterol 2008; 14: 2055-2060
3. Taghavi N, Nasrollahzadeh D, Merat S, Yazdanbod A, Hormazdi M, Sotoudeh M, Semnani S, Eslami F, Marjani HA, Fahimi S, Khademi H, Malekzadeh R. Epidemiology of upper gastrointestinal cancers in Iran: a sub site analysis of 761 cases. World J Gastroenterol 2007; 13: 5367-5370
4. Yaghoobi M, Rakhshani N, Sadr F, Bijarchi R, Joshaghani Y, Mohammadkhani A, Attari A, Akbari MR, Hormazdi M, Malekzadeh R. Hereditary risk factors for the development of gastric cancer in younger patients. BMC Gastroenterol 2004; 4: 28
5. Panani AD. Cytogenetic and molecular aspects of gastric cancer: clinical implications. Cancer Lett 2008; 266: 99-115
6. Kountouras J, Zavos C, Chatzopoulos D, Katsinelos P. New aspects of Helicobacter pylori infection involvement in gastric oncogenesis. J Surg Res 2008; 146: 149-158
7. Tamura G. Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J Gastroenterol 2006; 12: 192-198
8. Jothy S. CD44 and its partners in metastasis. Clin Exp Metastasis 2003; 20: 195-201
9. Zavrides HN, Zizi-Sermpetzoglou A, Panousopoulos D, Athanasas G, Elemenoglou I, Peros G. Prognostic evaluation of CD44 expression in correlation with bcl-2 and p53 in colorectal cancer. Folia Histochem Cytobiol 2005; 43: 31-36
10. Wang DR, Chen GY, Liu XL, Miao Y, Xia JG, Zhu LH, Tang D. CD44v6 in peripheral blood and bone marrow of patients with gastric cancer as micro-metastasis. World J Gastroenterol 2006; 12: 36-42
11. Sneath RJ, Mangham DC. The normal structure and function of CD44 and its role in neoplasia. Mol Pathol 1998; 51: 191-200
12. Kajita M, Itoh Y, Chiba T, Mori H, Okada A, Kinoh H, Seiki M. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 2001; 153: 893-904
13. Setala L, Lipponen P, Tammi R, Tammi M, Eskelinen M, Alhava E, Kosma VM. Expression of CD44 and its variant isoform v3 has no prognostic value in gastric cancer. Histopathology 2001; 38: 13-20
14. Yoo CH, Noh SH, Kim H, Lee HY, Min JS. Prognostic significance of CD44 and nm23 expression in patients with stage II and stage IIIA gastric carcinoma. J Surg Oncol 1999; 71: 22-28
15. Dammrich J, Vollmers HP, Heider KH, Muller-Hermelink HK. Importance of different CD44v6 expression in human gastric intestinal and diffuse type cancers for metastatic lymphogenic spreading. J Mol Med 1995; 73: 395-401
16. Yamaguchi A, Goi T, Yu J, Hirono Y, Ishida M, Iida A, Kimura T, Takeuchi K, Katayama K, Hirose K. Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastasis and long-term prognosis. J Surg Oncol 2002; 79: 230-235
17. Heider KH, Dammrich J, Skroch-Angel P, Muller-Hermelink HK, Vollmers HP, Herrlich P, Ponta H. Differential expression of CD44 splice variants in intestinal-and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res 1993; 53: 4197-4203
18. Pure E, Cuff CA. A crucial role for CD44 in inflammation. Trends Mol Med 2001; 7: 213-221
19. Yoo CH, Noh SH. The Serum Assay of Soluble CD44 Standard, CD44 Variant 5, and CD44 Variant 6 in Patients with Gastric Cancer. Cancer Res Treat 2003; 35: 3-8
20. Marhaba R, Zoller M. CD44 in cancer progression: adhesion, migration and growth regulation. J Mol Histol 2004; 35: 211-231
21. Gunthert U, Stauder R, Mayer B, Terpe HJ, Finke L, Friedrichs K. Are CD44 variant isoforms involved in human tumour progression? Cancer Surv 1995; 24: 19-42
22. Yokozaki H, Ito R, Nakayama H, Kuniyasu H, Taniyama K, Tahara E. Expression of CD44 abnormal transcripts in human gastric carcinomas. Cancer Lett 1994; 83: 229-234
23. Stock M, Otto F. Gene deregulation in gastric cancer. Gene 2005; 360: 1-19
24. Chen JQ, Zhan WH, He YL, Peng JS, Wang JP, Cai SR, Ma JP. Expression of heparanase gene, CD44v6, MMP-7 and nm23 protein and their relationship with the invasion and metastasis of gastric carcinomas. World J Gastroenterol 2004; 10: 776-782
25. Hsieh HF, Yu JC, Ho LI, Chiu SC, Harn HJ. Molecular studies into the role of CD44 variants in metastasis in gastric cancer. Mol Pathol 1999; 52: 25-28
26. Joo M, Lee HK, Kang YK. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis. Anticancer Res 2003; 23: 1581-1588
27. Liu YJ, Yan PS, Li J, Jia JF. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer. World J Gastroenterol 2005; 11: 6601-6606
28. Chen GY, Wang DR. The expression and clinical significance of CD44v in human gastric cancers. World J Gastroenterol 2000; 6: 125-127
29. Saito H, Tsujitani S, Katano K, Ikeguchi M, Maeta M, Kaibara N. Serum concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinoma. Cancer 1998; 83: 1094-1101
30. Castella EM, Ariza A, Pellicer I, Fernandez-Vasalo A, Ojanguren I. Differential expression of CD44v6 in metastases of intestinal and diffuse types of gastric carcinoma. J Clin Pathol 1998; 51: 134-137
31. Hong RL, Lee WJ, Shun CT, Chu JS, Chen YC. Expression of CD44 and its clinical implication in diffuse-type and intestinal-type gastric adenocarcinomas. Oncology 1995; 52: 334-339